Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 39.83 | 06:00:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 39.83 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 12.96 - 62.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 39.83 | USD |
Biohaven (BHVN) Options Flow Summary
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.25B | 81.58M | - | 0 | -408.17M | -5.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biohaven News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 41.15 | 41.88 | 36.77 | 39.16 | 1,421,418 | -1.32 | -3.21% |
| 1 Month | 50.99 | 55.72 | 36.77 | 43.91 | 1,453,705 | -11.16 | -21.89% |
| 3 Months | 47.77 | 62.21 | 36.77 | 50.26 | 1,360,050 | -7.94 | -16.62% |
| 6 Months | 26.97 | 62.21 | 25.97 | 44.03 | 1,235,718 | 12.86 | 47.68% |
| 1 Year | 13.08 | 62.21 | 12.96 | 33.41 | 1,171,025 | 26.75 | 204.51% |
| 3 Years | 75.23 | 152.56 | 7.10 | 64.66 | 1,045,558 | -35.40 | -47.06% |
| 5 Years | 62.98 | 152.56 | 7.10 | 62.24 | 923,364 | -23.15 | -36.76% |
Biohaven Description
| Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. |
